The results showed that a combined evaluation of DCE-MRI and DKI parameters reveals the best prediction of high-grade vs. low-grade gliomas, IDH1/2 wildtype vs. mutated gliomas, and astrocytomas/glioblastomas vs. oligodendrogliomas. This evidence concerns the gene IDH1 and central nervous system cancer.